SCHEMBL17714909

SCHEMBL17714909

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc5c4c4ccccc4n5-c4ccc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)cc4)c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ MAPT P10636 4/20 0.35
▸ HPGD P15428 4/20 0.35
▸ LMNA P02545 2/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ HDAC4 P56524 1/20 0.34
▸ NTSR1 P30989 1/20 0.34
▸ GLA P06280 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ FLT3 P36888 1/20 0.32
▸ BMX P51813 1/20 0.32
▸ TSPO P30536 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17714844 0.98 KDM4E (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL21111160 0.97 KDM4E (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL16805624 0.97 KDM4E (0.39) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL16805626 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL19818880 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17252435 0.96 KDM4E (0.40) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL22310291 0.95 KDM4E (0.36) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL20655068 0.95 MEN1 (0.37) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17714726 0.95 MEN1 (0.38) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL26450920 0.95 KDM4E (0.38) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-09-07 — — US disclosed
EP-3015465-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEMICAL LTD (KR) 2019-09-04 — — EP disclosed
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-02 — — US disclosed
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2019-04-09 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2016-07-14 — — US disclosed
EP-3015465-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG Chem, Ltd. (KR) 2016-05-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253016-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 KDM4E 1531/4885L3MBTL1 699/4885ATM 2327/4885
US-20160204359-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1531/4885L3MBTL1 699/4885ATM 2327/4885
US-11111231-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CRY2, NR2E3 KDM4E 1531/4885L3MBTL1 699/4885ATM 2327/4885
US-20190127352-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1531/4885L3MBTL1 699/4885ATM 2327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback